Century Therapeutics, Inc.
US ˙ NasdaqCM ˙ US15673T1007

SecurityIPSC / Century Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership26,249 shares
Latest Disclosed Value $ 59,323
Morgan Stanley ownership in IPSC / Century Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 26,249 shares of Century Therapeutics, Inc. (US:IPSC) valued at $59,323 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 0 shares of Century Therapeutics, Inc.. The current value of the position is $54,335 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CENTURY THERAPEUTICS COM 15673T100 26,249 26,249 59 0.0000
2026-05-27 2025-12-31 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 0 -118 -100.00 0 0.0000
2026-02-13 2025-12-31 13F CENTURY THERAPEUTICS COM 15673T100 0 -118 0 0.0000
2026-05-27 2025-09-30 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 118 -11,222 -98.96 0 -100.00 0.0000
2025-11-14 2025-09-30 13F CENTURY THERAPEUTICS COM 15673T100 118 -11,222 0 0.0000
2025-08-15 2025-06-30 13F CENTURY THERAPEUTICS COM 15673T100 11,340 -46,127 -80.27 6 -77.78 0.0000
2025-05-15 2025-03-31 13F CENTURY THERAPEUTICS COM 15673T100 57,467 -213,558 -78.80 27 -90.11 0.0000
2025-05-15 2024-12-31 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 271,025 -1,998,197 -88.06 274 -92.96 0.0000
2025-02-14 2024-12-31 13F CENTURY THERAPEUTICS COM 15673T100 271,025 -1,998,197 274 0.0000
2025-05-14 2024-09-30 13F/A-2 CENTURY THERAPEUTICS COM 15673T100 2,269,222 2,040,609 892.60 3,880 566.67 0.0003
2025-02-14 2024-09-30 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 2,269,222 2,040,609 3,880 0.0003
2024-11-14 2024-09-30 13F CENTURY THERAPEUTICS COM 15673T100 2,269,222 2,040,609 3,880 0.0000
2025-05-14 2024-06-30 13F/A-2 CENTURY THERAPEUTICS COM 15673T100 228,613 14,233 6.64 583 -35.04 0.0000
2024-10-17 2024-06-30 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 228,613 14,233 583 0.0000
2024-08-14 2024-06-30 13F CENTURY THERAPEUTICS COM 15673T100 228,613 14,233 583 0.0000
2024-10-17 2024-03-31 13F/A-2 CENTURY THERAPEUTICS COM 15673T100 214,380 -65,548 -23.42 896 -3.55 0.0001
2024-08-16 2024-03-31 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 214,380 -65,548 896 0.0000
2024-05-15 2024-03-31 13F CENTURY THERAPEUTICS COM 15673T100 214,380 -65,548 896 0.0001
2024-08-16 2023-12-31 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 279,928 -44,580 -13.74 929 43.14 0.0001
2024-02-13 2023-12-31 13F CENTURY THERAPEUTICS COM 15673T100 279,928 -44,580 929 0.0001
2023-11-15 2023-09-30 13F CENTURY THERAPEUTICS COM 15673T100 324,508 137,339 73.38 649 9.81 0.0001
2023-08-14 2023-06-30 13F CENTURY THERAPEUTICS COM 15673T100 187,169 134,833 257.63 591 226.52 0.0001
2023-05-15 2023-03-31 13F CENTURY THERAPEUTICS COM 15673T100 52,336 28,249 117.28 182 47.15 0.0000
2023-02-14 2022-12-31 13F CENTURY THERAPEUTICS COM 15673T100 24,087 5,675 30.82 124 -32.42 0.0000
2022-11-14 2022-09-30 13F CENTURY THERAPEUTICS COM 15673T100 18,412 -392,373 -95.52 182 -94.73 0.0000
2022-10-27 2022-06-30 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 410,785 27,283 7.11 3,451 -28.52 0.0004
2022-08-15 2022-06-30 13F CENTURY THERAPEUTICS COM 15673T100 410,785 27,283 3,451 0.0004
2022-10-27 2022-03-31 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 383,502 -62,914 -14.09 4,828 -31.82 0.0007
2022-05-13 2022-03-31 13F CENTURY THERAPEUTICS COM 15673T100 383,502 -62,914 4,828 0.0007
2022-02-14 2021-12-31 13F CENTURY THERAPEUTICS COM 15673T100 446,416 114,547 34.52 7,081 -15.21 0.0009
2021-11-15 2021-09-30 13F CENTURY THERAPEUTICS COM 15673T100 331,869 -4,354 -1.29 8,351 -15.35 0.0011
2021-08-23 2021-06-30 13F/A-1 CENTURY THERAPEUTICS COM 15673T100 336,223 336,223 9,865 0.0013
2021-08-16 2021-06-30 13F CENTURY THERAPEUTICS COM 15673T100 336,223 336,223 9,865 0.0013
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.